Insider Transactions in Q4 2023 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2023
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.65%
|
$105,000
$35.89 P/Share
|
|
Dec 21
2023
|
Dana Pizzuti Chief Med and Dev Officer |
SELL
Open market or private sale
|
Direct |
9,583
-61.85%
|
$325,822
$34.57 P/Share
|
|
Dec 21
2023
|
Dana Pizzuti Chief Med and Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,583
+38.21%
|
$153,328
$16.89 P/Share
|
|
Dec 11
2023
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.52%
|
$96,000
$32.87 P/Share
|
|
Nov 27
2023
|
Stephen F. Betz Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,000
-3.4%
|
$93,000
$31.84 P/Share
|
|
Nov 09
2023
|
Richard Scott Struthers President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+21.23%
|
$50,000
$1.91 P/Share
|
|
Nov 03
2023
|
Richard Scott Struthers President & CEO |
SELL
Open market or private sale
|
Direct |
199,082
-59.5%
|
$5,972,460
$30.56 P/Share
|
|
Nov 03
2023
|
Richard Scott Struthers President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
199,082
+37.3%
|
$1,791,738
$9.28 P/Share
|
|
Nov 02
2023
|
Richard Scott Struthers President & CEO |
SELL
Open market or private sale
|
Direct |
918
-0.67%
|
$26,622
$29.95 P/Share
|
|
Nov 02
2023
|
Richard Scott Struthers President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
918
+0.67%
|
$8,262
$9.28 P/Share
|
|
Nov 01
2023
|
Marc Wilson CFO |
SELL
Open market or private sale
|
Direct |
10,000
-9.47%
|
$280,000
$28.75 P/Share
|
|
Nov 01
2023
|
Marc Wilson CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.65%
|
$90,000
$9.28 P/Share
|
|
Oct 17
2023
|
Alan Seth Krasner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,000
-13.94%
|
$210,000
$30.0 P/Share
|
|
Oct 17
2023
|
Alan Seth Krasner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+12.24%
|
$84,000
$12.01 P/Share
|